Developmental Therapeutics Consortium

The Developmental Therapeutics Consortium (DTC) is a non-profit research organization dedicated to accelerating the clinical development of innovative cancer therapies. Based in Chicago, the consortium operates as a collaborative bridge between academic institutions and the pharmaceutical industry to conduct early-phase clinical trials. A hallmark of the DTC's mission is the advancement of Interventional Pharmacoeconomics, a field focused on optimizing drug dosing and repurposing existing medications to improve affordability and patient access. By leveraging the clinical and scientific expertise of its member universities, the DTC validates new treatment strategies that aim to maintain efficacy while significantly reducing healthcare costs. The organization's work is particularly influential in the areas of value-based oncology and personalized medicine.